PortfoliosLab logo

Agile Therapeutics, Inc. (AGRX)

Equity · Currency in USD · Last updated Nov 29, 2022

Company Info

ISINUS00847L1008
CUSIP00847L100
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Trading Data

Previous Close$0.20
Year Range$0.19 - $28.24
EMA (50)$0.31
EMA (200)$5.43
Average Volume$973.67K
Market Capitalization$8.04M

AGRXShare Price Chart


Loading data...

AGRXPerformance

The chart shows the growth of $10,000 invested in Agile Therapeutics, Inc. in May 2014 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $9 for a total return of roughly -99.91%. All prices are adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%JulyAugustSeptemberOctoberNovember
-85.48%
-3.35%
AGRX (Agile Therapeutics, Inc.)
Benchmark (^GSPC)

AGRXCompare to other instruments

Search for stocks, ETFs, and funds to compare with AGRX

AGRXReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-26.02%1.61%
6M-87.16%-4.67%
YTD-98.98%-16.83%
1Y-99.10%-13.73%
5Y-75.10%8.59%
10Y-56.16%9.02%

AGRXMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-28.50%-12.32%-31.54%-72.67%-38.86%-16.79%-56.15%-21.12%-26.30%-6.06%-28.67%
2021-1.74%1.77%-27.53%-11.06%-12.97%-17.39%-9.77%-3.33%-17.15%-17.45%-20.59%-22.52%
202048.00%-27.70%-30.47%30.38%16.29%-1.42%-10.07%28.00%-5.00%-10.53%3.68%1.77%
201940.65%11.23%67.59%0.66%-17.76%16.80%-20.55%-5.17%7.73%1.27%75.00%19.05%
201821.93%10.67%-29.20%10.12%-80.21%-11.79%-40.69%-0.00%25.09%129.41%3.15%-33.60%
2017-59.65%-3.48%44.37%12.01%-8.64%14.33%26.40%-27.43%29.65%6.50%5.47%-46.31%
2016-37.50%-5.57%7.81%-6.76%38.17%-4.87%-8.02%3.43%-3.59%8.88%-9.61%-17.03%
201541.69%24.60%-14.48%25.35%-18.59%-9.20%6.29%-3.29%-23.67%17.80%12.34%9.42%
20145.60%49.06%-28.33%35.04%-13.51%-2.74%-16.20%3.19%

AGRXSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Agile Therapeutics, Inc. Sharpe ratio is -0.65. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.200.00JulyAugustSeptemberOctoberNovember
-0.65
-0.57
AGRX (Agile Therapeutics, Inc.)
Benchmark (^GSPC)

AGRXDividend History


Agile Therapeutics, Inc. doesn't pay dividends

AGRXDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovember
-99.96%
-17.36%
AGRX (Agile Therapeutics, Inc.)
Benchmark (^GSPC)

AGRXWorst Drawdowns

The table below shows the maximum drawdowns of the Agile Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Agile Therapeutics, Inc. is 99.96%, recorded on Nov 21, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.96%Apr 17, 20151915Nov 21, 2022
-45.35%Jun 25, 2014122Dec 16, 201449Feb 27, 2015171
-20.5%Mar 5, 201515Mar 25, 20158Apr 7, 201523
-9.22%Jun 4, 20142Jun 5, 20144Jun 11, 20146
-3.04%Jun 20, 20141Jun 20, 20141Jun 23, 20142
-2.02%Jun 16, 20141Jun 16, 20141Jun 17, 20142
-1.52%May 30, 20141May 30, 20141Jun 2, 20142
-0.51%Apr 9, 20151Apr 9, 20151Apr 10, 20152
-0.37%Mar 2, 20151Mar 2, 20151Mar 3, 20152

AGRXVolatility Chart

Current Agile Therapeutics, Inc. volatility is 68.47%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%100.00%200.00%300.00%400.00%500.00%600.00%JulyAugustSeptemberOctoberNovember
68.47%
14.31%
AGRX (Agile Therapeutics, Inc.)
Benchmark (^GSPC)